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Background
Several cases of allergy to goat’s milk (GM) without allergy
to cow’s milk (CM) have been reported. GM-allergy has
also been reported in CM-allergic children successfully
treated with oral immunotherapy. We previously demon-
strated that IgE antibodies from GM-allergic/CM-tolerant
patients recognize the caprine b-casein (bcap) without
cross-reacting with the bovine b-casein (bbov) despite a
high sequence identity (91%). We aimed in the present
work to identify the critical amino acids in the non-cross-
reactive IgE-binding epitopes of bcap.
Methods
Using site-directed mutagenesis, recombinant bcap was
modified by performing residue substitutions with the
corresponding amino acids found in bbov. The IgE-
binding capacity of the different modified bcap was then
evaluated with sera from 9 GM-allergic/CM-tolerant
patients and 9 CM-allergic patients. The specificity of
murine monoclonal antibodies (mAb) raised against
caprine caseins was also analyzed in order to further
characterize non-cross-reactive epitopes. The allergenic
activity of recombinant bcap was finally assessed by
degranulation tests of RBL cells passively sensitized with
human IgE antibodies.
Results
The substitutions A55T/T63P/L75P in the N-terminal
part and P148H/S152P in the C-terminal part of bcap
induced the greatest decrease of IgE-reactivity of GM-
allergic/CM-tolerant patients toward the caprine aller-
gen. The threonine 63 was found to be particularly criti-
cal, as confirmed by the specificity of mAb SCB1D,
whose ability to bind bcap was abolished by the substi-
tution T63P. The recombinant bcap containing the five
substitutions was unable to induce the degranulation of
RBL cells passively sensitized with IgE from GM-aller-
gic/CM-tolerant patients but was still fully allergenic
when testing sera from CM-allergic patients.
Conclusion
Most of the critical substitutions supporting the
restricted IgE specificity of GM-allergic/CM-tolerant
patients toward bcap involved proline residues. This
probably affects both the primary and secondary struc-
tures of non-cross-reactive epitopes since proline are
frequently found in turns in protein structures. The
drastic influence of substitution T63P on the binding of
mAB SCB1D to bcap confirmed the immunodominant
role of the epitope encompassing threonine 63, as initi-
ally observed with GM-allergic/CM-tolerant patients.
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